1. Home
  2. GDRX vs EVO Comparison

GDRX vs EVO Comparison

Compare GDRX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

HOLD

Current Price

$2.98

Market Cap

999.1M

Sector

Technology

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.88

Market Cap

994.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDRX
EVO
Founded
2011
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
999.1M
994.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GDRX
EVO
Price
$2.98
$2.88
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$3.66
$7.00
AVG Volume (30 Days)
1.2M
29.8K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
125.00
N/A
EPS
N/A
N/A
Revenue
$796,853,000.00
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
$5.38
$10.05
P/E Ratio
$28.94
N/A
Revenue Growth
0.57
N/A
52 Week Low
$1.77
$2.31
52 Week High
$5.61
$4.42

Technical Indicators

Market Signals
Indicator
GDRX
EVO
Relative Strength Index (RSI) 64.75 57.27
Support Level $2.47 $2.88
Resistance Level $3.12 $3.30
Average True Range (ATR) 0.13 0.06
MACD 0.03 0.03
Stochastic Oscillator 85.94 91.89

Price Performance

Historical Comparison
GDRX
EVO

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: